Literature DB >> 27289125

Precision Medicine in Diabetes: Is It Time?

Jose C Florez1.   

Abstract

Entities:  

Year:  2016        PMID： 27289125     DOI： 10.2337/dc16-0586

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  14 in total

1.  Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.

Authors:  William T Cefalu; Dana K Andersen; Guillermo Arreaza-Rubín; Christopher L Pin; Sheryl Sato; C Bruce Verchere; Minna Woo; Norman D Rosenblum
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 17.152

Review 2.  Precision Diabetes Is Slowly Becoming a Reality.

Authors:  Viswanathan Mohan; Venkatesan Radha
Journal:  Med Princ Pract       Date:  2019-01-27       Impact factor: 1.927

3.  The Impact of Precision Medicine in Diabetes: A Multidimensional Perspective.

Authors:  Stephen S Rich; William T Cefalu
Journal:  Diabetes Care       Date:  2016-11       Impact factor: 19.112

4.  Diabetes Care: "Lagniappe" and "Seeing Is Believing"!

Authors:  William T Cefalu; Andrew J M Boulton; William V Tamborlane; Robert G Moses; Derek LeRoith; Eddie L Greene; Frank B Hu; George Bakris; Judith Wylie-Rosett; Julio Rosenstock; Katie Weinger; Lawrence Blonde; Mary de Groot; Stephen S Rich; David D'Alessio; Matthew C Riddle; Lyn Reynolds
Journal:  Diabetes Care       Date:  2016-06-09       Impact factor: 19.112

5.  Diabetes Care: "Taking It to the Limit One More Time".

Authors:  William T Cefalu; Andrew J M Boulton; William V Tamborlane; Robert G Moses; Derek LeRoith; Eddie L Greene; Frank B Hu; George Bakris; Judith Wylie-Rosett; Julio Rosenstock; Steven E Kahn; Katie Weinger; Lawrence Blonde; Mary de Groot; Stephen Rich; David D'Alessio; Lyn Reynolds; Matthew C Riddle
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

6.  Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective.

Authors:  Enrico Capobianco
Journal:  Clin Transl Med       Date:  2017-07-25

7.  Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy.

Authors:  John M Dennis; Beverley M Shields; Anita V Hill; Bridget A Knight; Timothy J McDonald; Lauren R Rodgers; Michael N Weedon; William E Henley; Naveed Sattar; Rury R Holman; Ewan R Pearson; Andrew T Hattersley; Angus G Jones
Journal:  Diabetes Care       Date:  2018-01-31       Impact factor: 19.112

Review 8.  Precision Health Care Elements, Definitions, and Strategies for Patients with Diabetes: A Literature Review.

Authors:  Satriya Pranata; Shu-Fang Vivienne Wu; Javad Alizargar; Ju-Han Liu; Shu-Yuan Liang; Yu-Ying Lu
Journal:  Int J Environ Res Public Health       Date:  2021-06-17       Impact factor: 3.390

9.  TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes.

Authors:  Maria J Redondo; Susan Geyer; Andrea K Steck; Jay Sosenko; Mark Anderson; Peter Antinozzi; Aaron Michels; John Wentworth; Ping Xu; Alberto Pugliese
Journal:  Diabetes Care       Date:  2017-10-12       Impact factor: 19.112

10.  A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy.

Authors:  Anita L Grubb; Timothy J McDonald; Femke Rutters; Louise A Donnelly; Andrew T Hattersley; Richard A Oram; Colin N A Palmer; Amber A van der Heijden; Fiona Carr; Petra J M Elders; Mike N Weedon; Roderick C Slieker; Leen M 't Hart; Ewan R Pearson; Beverley M Shields; Angus G Jones
Journal:  Diabetes Care       Date:  2018-10-23       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.